Literature DB >> 28158293

Phosphorylated fraction of H2AX as a measurement for DNA damage in cancer cells and potential applications of a novel assay.

Jiuping Ji1, Yiping Zhang1, Christophe E Redon2, William C Reinhold2, Alice P Chen3, Laura K Fogli4, Susan L Holbeck4, Ralph E Parchment1, Melinda Hollingshead4, Joseph E Tomaszewski4, Quentin Dudon2, Yves Pommier2, James H Doroshow2,4, William M Bonner2.   

Abstract

Phosphorylated H2AX (γ-H2AX) is a sensitive marker for DNA double-strand breaks (DSBs), but the variability of H2AX expression in different cell and tissue types makes it difficult to interpret the meaning of the γ-H2AX level. Furthermore, the assays commonly used for γ-H2AX detection utilize laborious and low-throughput microscopy-based methods. We describe here an ELISA assay that measures both phosphorylated H2AX and total H2AX absolute amounts to determine the percentage of γ-H2AX, providing a normalized value representative of the amount of DNA damage. We demonstrate the utility of the assay to measure DSBs introduced by either ionizing radiation or DNA-damaging agents in cultured cells and in xenograft models. Furthermore, utilizing the NCI-60 cancer cell line panel, we show a correlation between the basal fraction of γ-H2AX and cellular mutation levels. This additional application highlights the ability of the assay to measure γ-H2AX levels in many extracts at once, making it possible to correlate findings with other cellular characteristics. Overall, the γ-H2AX ELISA represents a novel approach to quantifying DNA damage, which may lead to a better understanding of mutagenic pathways in cancer and provide a useful biomarker for monitoring the effectiveness of DNA-damaging anticancer agents.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28158293      PMCID: PMC5291513          DOI: 10.1371/journal.pone.0171582

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  52 in total

1.  Extraction, purification and analysis of histones.

Authors:  David Shechter; Holger L Dormann; C David Allis; Sandra B Hake
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

Review 2.  Histone variants in pluripotency and disease.

Authors:  Peter J Skene; Steven Henikoff
Journal:  Development       Date:  2013-06       Impact factor: 6.868

3.  Erlotinib: an EGF receptor tyrosine kinase inhibitor in non-small-cell lung cancer treatment.

Authors:  Clorinda Schettino; Maria Anna Bareschino; Vincenzo Ricci; Fortunato Ciardiello
Journal:  Expert Rev Respir Med       Date:  2008-04       Impact factor: 3.772

4.  GammaH2AX in cancer cells: a potential biomarker for cancer diagnostics, prediction and recurrence.

Authors:  Olga A Sedelnikova; William M Bonner
Journal:  Cell Cycle       Date:  2006-12-15       Impact factor: 4.534

Review 5.  DNA damage, aging, and cancer.

Authors:  Jan H J Hoeijmakers
Journal:  N Engl J Med       Date:  2009-10-08       Impact factor: 91.245

6.  The use of Olaparib (AZD2281) potentiates SN-38 cytotoxicity in colon cancer cells by indirect inhibition of Rad51-mediated repair of DNA double-strand breaks.

Authors:  Makiko Tahara; Takeshi Inoue; Futoshi Sato; Yasuyuki Miyakura; Hisanaga Horie; Yoshikazu Yasuda; Hirofumi Fujii; Kenjiro Kotake; Kokichi Sugano
Journal:  Mol Cancer Ther       Date:  2014-02-27       Impact factor: 6.261

Review 7.  DNA repair, genome stability and cancer: a historical perspective.

Authors:  Penny A Jeggo; Laurence H Pearl; Antony M Carr
Journal:  Nat Rev Cancer       Date:  2015-12-15       Impact factor: 60.716

8.  A global reference for human genetic variation.

Authors:  Adam Auton; Lisa D Brooks; Richard M Durbin; Erik P Garrison; Hyun Min Kang; Jan O Korbel; Jonathan L Marchini; Shane McCarthy; Gil A McVean; Gonçalo R Abecasis
Journal:  Nature       Date:  2015-10-01       Impact factor: 49.962

9.  RAD18 transmits DNA damage signalling to elicit homologous recombination repair.

Authors:  Jun Huang; Michael S Y Huen; Hongtae Kim; Charles Chung Yun Leung; J N Mark Glover; Xiaochun Yu; Junjie Chen
Journal:  Nat Cell Biol       Date:  2009-04-26       Impact factor: 28.824

10.  Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors.

Authors:  Junko Murai; Shar-yin N Huang; Benu Brata Das; Amelie Renaud; Yiping Zhang; James H Doroshow; Jiuping Ji; Shunichi Takeda; Yves Pommier
Journal:  Cancer Res       Date:  2012-11-01       Impact factor: 13.312

View more
  27 in total

1.  Radiotherapy induces cell cycle arrest and cell apoptosis in nasopharyngeal carcinoma via the ATM and Smad pathways.

Authors:  Ming-Yi Li; Jin-Quan Liu; Dong-Ping Chen; Zhou-Yu Li; Bin Qi; Lu He; Yi Yu; Wen-Jin Yin; Meng-Yao Wang; Ling Lin
Journal:  Cancer Biol Ther       Date:  2017-09-02       Impact factor: 4.742

2.  Discovery of Novel Small-Molecule Scaffolds for the Inhibition and Activation of WIP1 Phosphatase from a RapidFire Mass Spectrometry High-Throughput Screen.

Authors:  Victor Clausse; Yuhong Fang; Dingyin Tao; Harichandra D Tagad; Hongmao Sun; Yuhong Wang; Surendra Karavadhi; Kelly Lane; Zhen-Dan Shi; Olga Vasalatiy; Christopher A LeClair; Rebecca Eells; Min Shen; Samarjit Patnaik; Ettore Appella; Nathan P Coussens; Matthew D Hall; Daniel H Appella
Journal:  ACS Pharmacol Transl Sci       Date:  2022-09-28

3.  CellMiner Cross-Database (CellMinerCDB) version 1.2: Exploration of patient-derived cancer cell line pharmacogenomics.

Authors:  Augustin Luna; Fathi Elloumi; Sudhir Varma; Yanghsin Wang; Vinodh N Rajapakse; Mirit I Aladjem; Jacques Robert; Chris Sander; Yves Pommier; William C Reinhold
Journal:  Nucleic Acids Res       Date:  2021-01-08       Impact factor: 16.971

4.  Novel Fluoroindenoisoquinoline Non-Camptothecin Topoisomerase I Inhibitors.

Authors:  Laetitia Marzi; Keli Agama; Junko Murai; Simone Difilippantonio; Amy James; Cody J Peer; William D Figg; Daniel Beck; Mohamed S A Elsayed; Mark Cushman; Yves Pommier
Journal:  Mol Cancer Ther       Date:  2018-05-10       Impact factor: 6.261

5.  Survivin Expression Is Differentially Regulated by a Selective Cross-talk between RBM38 and miRNAs let-7b or miR-203a.

Authors:  Christopher A Lucchesi; Jin Zhang; Buyong Ma; Ruth Nussinov; Xinbin Chen
Journal:  Cancer Res       Date:  2021-01-20       Impact factor: 13.312

Review 6.  Histone H2A variants: Diversifying chromatin to ensure genome integrity.

Authors:  Philipp Oberdoerffer; Kyle M Miller
Journal:  Semin Cell Dev Biol       Date:  2022-03-21       Impact factor: 7.499

7.  Autophagy modulates temozolomide-induced cell death in alveolar Rhabdomyosarcoma cells.

Authors:  Adel Rezaei Moghadam; Simone C da Silva Rosa; Ehsan Samiei; Javad Alizadeh; Jared Field; Philip Kawalec; James Thliveris; Mohsen Akbari; Saeid Ghavami; Joseph W Gordon
Journal:  Cell Death Discov       Date:  2018-10-25

8.  Increased DNA Damage and Apoptosis in CDKL5-Deficient Neurons.

Authors:  Manuela Loi; Stefania Trazzi; Claudia Fuchs; Giuseppe Galvani; Giorgio Medici; Laura Gennaccaro; Marianna Tassinari; Elisabetta Ciani
Journal:  Mol Neurobiol       Date:  2020-01-30       Impact factor: 5.590

Review 9.  The role of the DFF40/CAD endonuclease in genomic stability.

Authors:  Merve Kulbay; Nathan Bernier-Parker; Jacques Bernier
Journal:  Apoptosis       Date:  2021-01-02       Impact factor: 4.677

10.  NADPH oxidase 5 (NOX5)-induced reactive oxygen signaling modulates normoxic HIF-1α and p27Kip1 expression in malignant melanoma and other human tumors.

Authors:  Smitha Antony; Guojian Jiang; Yongzhong Wu; Jennifer L Meitzler; Hala R Makhlouf; Diana C Haines; Donna Butcher; Dave S Hoon; Jiuping Ji; Yiping Zhang; Agnes Juhasz; Jiamo Lu; Han Liu; Iris Dahan; Mariam Konate; Krishnendu K Roy; James H Doroshow
Journal:  Mol Carcinog       Date:  2017-08-30       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.